Microbot Medical
MBOT
40 hedge funds and large institutions have $11.3M invested in Microbot Medical in 2014 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 5 closing their positions.
140% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 5
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
3% more funds holding
Funds holding: 39 → 40 (+1)
30% less capital invested
Capital invested by funds: $16.1M → $11.3M (-$4.78M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.09M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$162K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$109K |
| 4 |
D.E. Shaw & Co
New York
|
+$78.1K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$45.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.02M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$612K |
| 3 |
Goldman Sachs
New York
|
-$101K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$20K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$16.3K |
MBOT Hedge Fund Activity: Q4 2014 in Review
40 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q4 2014, worth a combined $11.3M — down 30% from $16.1M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new MBOT positions and 5 closed out — a net gain of 2 holders — while 12 added to existing stakes and 5 trimmed.
The largest buyer was Sabby Management, adding an estimated $1.09M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $2.02M sold.
- 40 institutional investors held Microbot Medical (MBOT) as of Q4 2014, up from 39 in Q3 2014.
- Funds reported $11.3M of Microbot Medical stock for Q4 2014, down 30% quarter-over-quarter.
- 7 funds opened new Microbot Medical positions in Q4 2014 and 5 closed out, a net change of +2 holders.
- The largest Microbot Medical buyer in Q4 2014 was Sabby Management, an estimated $1.09M added.
- The largest Microbot Medical seller in Q4 2014 was Susquehanna International Group, an estimated $2.02M sold.
Based on aggregated 13F filings for Q4 2014.